Plasma concentrations of individual tea catechins after a single oral dose in humans
- PMID: 11780763
- DOI: 10.1080/00498250110079149
Plasma concentrations of individual tea catechins after a single oral dose in humans
Abstract
1. Ten healthy volunteers ingested 1.5 mmole epicatechin gallate (ECg), epigallocatechin (EGC) or epigallocatechin gallate (EGCg) in a randomized crossover design. After deconjugation, catechins in plasma and 24-h urine samples were determined by high-performance liquid chromatography (HPLC). Antioxidant activity was measured in plasma by determining ferric reducing activity (FRAP). 2. The catechin levels in plasma after ingestion were significantly different: EGC rose quickly with a short elimination half-life (t1/2 elim = 1.7 h), ECg was intermediate in rise but slowest in decline (t1/2 elim = 6.9h), EGCg was slowest in rise but intermediate in decline (t1/2 elim = 3.9h). At 24h, EGC and EGCg had returned to base levels, but ECg was still elevated. Peak maximum varied between 1.3 (EGCg) and 5.0 micromol l(-1) (EGC). 3. Very limited interconversion (ECg-->epicatechin, EGCg-->EGC) occurred indicating that degallation is not required for uptake. 4. Up to 13.6% of the ingested EGC (partly methylated) was excreted in the urine, but ECg or EGCg were not detected. 5. EGC and ECg produced an increase in antioxidant activity in plasma, but with EGCg, no statistically significant effect was found. 6. The pattern of uric acid in plasma showed a clear resemblance with that of FRAP and linear regression analysis indicated a very significant relationship (R2 = 0.88, p < 0.0001). 7. It is concluded that tea catechins differ significantly in their pharmacokinetic behaviour.
Similar articles
-
Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis).Br J Nutr. 2013 Jun 28;109(12):2199-207. doi: 10.1017/S0007114512004370. Epub 2012 Oct 30. Br J Nutr. 2013. PMID: 23110850
-
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.Clin Cancer Res. 2005 Jun 15;11(12):4627-33. doi: 10.1158/1078-0432.CCR-04-2549. Clin Cancer Res. 2005. PMID: 15958649 Clinical Trial.
-
Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376503
-
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):53-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11205489 Clinical Trial.
-
Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma.Biosci Biotechnol Biochem. 1997 Dec;61(12):1981-5. doi: 10.1271/bbb.61.1981. Biosci Biotechnol Biochem. 1997. PMID: 9438978 Clinical Trial.
Cited by
-
Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment.Int J Mol Sci. 2024 Feb 25;25(5):2671. doi: 10.3390/ijms25052671. Int J Mol Sci. 2024. PMID: 38473918 Free PMC article. Review.
-
Gallation and B-Ring Dihydroxylation Increase Green Tea Catechin Residence Time in Plasma by Differentially Affecting Tissue-Specific Trafficking: Compartmental Model of Catechin Kinetics in Healthy Adults.Nutrients. 2023 Sep 17;15(18):4021. doi: 10.3390/nu15184021. Nutrients. 2023. PMID: 37764804 Free PMC article.
-
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.Nutrients. 2023 Jul 3;15(13):3022. doi: 10.3390/nu15133022. Nutrients. 2023. PMID: 37447347 Free PMC article. Review.
-
Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis.Int J Mol Sci. 2022 Dec 25;24(1):340. doi: 10.3390/ijms24010340. Int J Mol Sci. 2022. PMID: 36613784 Free PMC article. Review.
-
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?Antioxidants (Basel). 2022 Aug 13;11(8):1566. doi: 10.3390/antiox11081566. Antioxidants (Basel). 2022. PMID: 36009285 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous